Cargando…
MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188466/ https://www.ncbi.nlm.nih.gov/pubmed/37206275 http://dx.doi.org/10.1002/jha2.690 |
| _version_ | 1785042919133020160 |
|---|---|
| author | Torabi, Alireza Fromm, Jonathan R Naresh, Kikkeri N |
| author_facet | Torabi, Alireza Fromm, Jonathan R Naresh, Kikkeri N |
| author_sort | Torabi, Alireza |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10188466 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101884662023-05-18 MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma Torabi, Alireza Fromm, Jonathan R Naresh, Kikkeri N EJHaem Haematology Images John Wiley and Sons Inc. 2023-04-13 /pmc/articles/PMC10188466/ /pubmed/37206275 http://dx.doi.org/10.1002/jha2.690 Text en © 2023 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Haematology Images Torabi, Alireza Fromm, Jonathan R Naresh, Kikkeri N MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma |
| title | MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma |
| title_full | MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma |
| title_fullStr | MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma |
| title_full_unstemmed | MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma |
| title_short | MEF2B is the ideal immunohistochemical marker to highlight neoplastic LP cells in nodular lymphocyte‐predominant Hodgkin lymphoma |
| title_sort | mef2b is the ideal immunohistochemical marker to highlight neoplastic lp cells in nodular lymphocyte‐predominant hodgkin lymphoma |
| topic | Haematology Images |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188466/ https://www.ncbi.nlm.nih.gov/pubmed/37206275 http://dx.doi.org/10.1002/jha2.690 |
| work_keys_str_mv | AT torabialireza mef2bistheidealimmunohistochemicalmarkertohighlightneoplasticlpcellsinnodularlymphocytepredominanthodgkinlymphoma AT frommjonathanr mef2bistheidealimmunohistochemicalmarkertohighlightneoplasticlpcellsinnodularlymphocytepredominanthodgkinlymphoma AT nareshkikkerin mef2bistheidealimmunohistochemicalmarkertohighlightneoplasticlpcellsinnodularlymphocytepredominanthodgkinlymphoma |